BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 5396030)

  • 21. [A hypoglycemizing sulfamide associated with biguanide in the treatment of type I diabetes in adults].
    Plauchu M; Thevenon P
    Lyon Med; 1968 Oct; 220(42):953-63. PubMed ID: 5742623
    [No Abstract]   [Full Text] [Related]  

  • 22. [Activity of the pancreas glycogenase under oral biguanide and tolbutamide loading in diabetes].
    Schilling I; Jutzi E
    Dtsch Z Verdau Stoffwechselkr; 1967 Feb; 26(4):180-5. PubMed ID: 5595284
    [No Abstract]   [Full Text] [Related]  

  • 23. [Study of a new delayed-action biguanide].
    Plauchu M; Pousset G; Chapuy H; Amourdedieu J; Tuaillon J
    Lyon Med; 1969 Oct; 222(35):467-76. PubMed ID: 5401952
    [No Abstract]   [Full Text] [Related]  

  • 24. [Treatment of diabetes mellitus with dimethylbiguanide. Experience with 280 cases].
    Brugi A; Gironi G; Ferrari ML
    Clin Ter; 1967 Aug; 42(3):247-55. PubMed ID: 5608817
    [No Abstract]   [Full Text] [Related]  

  • 25. [Biguanide therapy of diabetes mellitus].
    Schreiber FK
    Dtsch Med Wochenschr; 1977 Mar; 102(12):456. PubMed ID: 844418
    [No Abstract]   [Full Text] [Related]  

  • 26. [Transaminase activity of the blood and bile in diabetes mellitus].
    Vladkovskiĭ IK; Mokhun' IK; Liashuk PM; Splavskiĭ OI; Ivanenko EI
    Vrach Delo; 1981 Jun; (6):74-5. PubMed ID: 7257304
    [No Abstract]   [Full Text] [Related]  

  • 27. [Lactate acidosis in biguanide therapy of diabetes mellitus].
    Klein W
    Dtsch Med Wochenschr; 1977 Jul; 102(27):1009. PubMed ID: 880896
    [No Abstract]   [Full Text] [Related]  

  • 28. [Indications and contraindications of biguanide therapy in diabetes mellitus].
    Tatón J
    Z Gesamte Inn Med; 1981 Jan; 36(2):33-7. PubMed ID: 7222845
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment of diabetics by biguanide--its applicability with special reference to clinical observations].
    Takeda M; Nishikawa K; Miki S; Fujii Y; Tatsumi K
    Nihon Naibunpi Gakkai Zasshi; 1968 Oct; 44(7):794-805. PubMed ID: 5752684
    [No Abstract]   [Full Text] [Related]  

  • 30. [Therapy of diabetes mellitus with Silubin-retard].
    Huczek-Glebocki J; Piotrowska R; Ruciński M
    Pol Tyg Lek; 1970 Jan; 25(1):26-7. PubMed ID: 5414476
    [No Abstract]   [Full Text] [Related]  

  • 31. [Lactic acid acidosis and biguanides--a review].
    Böttiger LE
    Lakartidningen; 1973 Oct; 70(40):3463-4. PubMed ID: 4207560
    [No Abstract]   [Full Text] [Related]  

  • 32. [Lactacidosis in biguanide therapy of diabetes mellitus].
    But H
    Dtsch Med Wochenschr; 1977 Nov; 102(44):1613. PubMed ID: 923437
    [No Abstract]   [Full Text] [Related]  

  • 33. [Lactate acidoses in biguanide therapy of diabetes mellitus].
    Raisp I
    Dtsch Med Wochenschr; 1977 Jul; 102(26):978. PubMed ID: 885082
    [No Abstract]   [Full Text] [Related]  

  • 34. [Treatment of controlled diabetes with sustained-action biguanides].
    Kowrygo W
    Wiad Lek; 1970 Apr; 23(7):527-31. PubMed ID: 5455895
    [No Abstract]   [Full Text] [Related]  

  • 35. Diabetes mellitus following a mumps epidemic.
    Khakpour M; Nik-Akhtar B
    J Trop Med Hyg; 1975 Dec; 78(12):262-3. PubMed ID: 1223328
    [No Abstract]   [Full Text] [Related]  

  • 36. [Silubin retard--long-term effects].
    Dub O; Brozek I; Pátek F
    Cas Lek Cesk; 1971 Jun; 110(25):591-4. PubMed ID: 5088225
    [No Abstract]   [Full Text] [Related]  

  • 37. [Treatment of diabetes mellitus with long-acting biguanides].
    Kliachko VR; Perelygina AA; Mazovetskiĭ AG; Slavina LS
    Probl Endokrinol (Mosk); 1976; 22(3):22-6. PubMed ID: 935083
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Therapeutic possibilities in diabetes mellitus with biguanides. Clinical experiences in 122 diabetics with dimethylbiguanide(Glucophage)].
    Berger W; Constam GR; Siegenthaler W
    Schweiz Med Wochenschr; 1966 Oct; 96(40):1335-42. PubMed ID: 5954279
    [No Abstract]   [Full Text] [Related]  

  • 39. [Comparative studies of the effect of N1-n-butylbiguanide hydrochloride (Buformin) and N1-n-butylbiguanide tosylate (Buformin retard)].
    Singer P; Thoelke H
    Z Gesamte Inn Med; 1973 Aug; 28(16):504-6. PubMed ID: 4767598
    [No Abstract]   [Full Text] [Related]  

  • 40. [The effect of butyl biguanide therapy on the serum lipid level in diabetics].
    Balázsi I; Bretán M; Végh M
    Orv Hetil; 1971 Jan; 112(4):193-4. PubMed ID: 5548910
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.